Literature DB >> 26034197

Novel use of the AngioVac® system to remove thrombus during simultaneous extracorporeal membrane oxygenation life support.

Kevin E Griffith1, Eric Jenkins2, William Copenhaver3, David M Williams4.   

Abstract

Extracorporeal membrane oxygenation (ECMO) was introduced to clinical medicine over 40 years ago. While initially used as a treatment for acute respiratory failure in infants, the use of ECMO has grown to include respiratory and circulatory failure in both children and adults, cardiogenic shock, pulmonary embolism, sepsis, trauma, malignancy, pulmonary hemorrhage and as a treatment for hypothermic drowning.(1) Recent technological improvements in ECMO circuitry make it possible to minimize anticoagulation of the ECMO patient, decreasing the incidence of bleeding. Thrombus deposition within the ECMO circuit can be a life-threating complication. ECMO circuit thrombus can be contained in the circuit, adherent to cannula and deposited within the patient. The ability to remove thrombus while the patient remains on ECMO support could be a life-saving measure for some patients. The present case report outlines use of the AngioVac(®) thrombus removal system in concert with ECMO to remove a large thrombus adherent to an ECMO cannula.
© The Author(s) 2015.

Entities:  

Keywords:  AngioVac; embolectomy; extracorporeal membrane oxygenation; pulmonary embolism; thrombectomy

Mesh:

Year:  2015        PMID: 26034197     DOI: 10.1177/0267659115589622

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  1 in total

1.  En Bloc AngioVac Removal of Thoracic Aortic Mass.

Authors:  Jeanney Kang; Fernando Fleischman; Farhood Saremi; David M Shavelle
Journal:  Tex Heart Inst J       Date:  2020-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.